Search research articles
Contact Us
Filters
Showing results (521-530 of 706) with videos related to
Page
of 71
Sort By:
Journal of the American College of Cardiology
|
May 7, 2011
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy
Benjamin M Scirica, Christopher P Cannon, Håkan Emanuelsson, et al.
International Journal of Cardiology
|
June 23, 2020
The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program
Clare Arnott, Brendon L Neuen, Hiddo J L Heerspink, et al.
Journal of the American Heart Association
|
April 16, 2017
Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding
Daniel Lindholm, Emil Hagström, Stefan K James, et al.
European Heart Journal
|
March 4, 2014
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry
Dharam J Kumbhani, Ph Gabriel Steg, Christopher P Cannon, et al.
Critical Pathways in Cardiology
|
March 15, 2008
Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry
Christopher P Cannon, Maria Cecilia Bahit, J Mark Haugland, et al.
American Heart Journal
|
May 21, 2019
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
Axel Åkerblom, Daniel M Wojdyla, Lars Wallentin, et al.
Journal of Clinical Lipidology
|
September 15, 2020
Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in the ODYSSEY CHOICE I trial
Eli M Roth, John J P Kastelein, Christopher P Cannon, et al.
JAMA Cardiology
|
January 21, 2026
Patient Engagement With Home Blood Pressure Monitoring
Ozan Unlu, David Zelle, Christopher P Cannon, et al.
Journal of the American College of Cardiology
|
June 7, 2005
Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates
Ajay J Kirtane, David M Leder, Sushrut S Waikar, et al.
Circulation. Cardiovascular Quality and Outcomes
|
January 12, 2012
Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program
Feng Qian, Frederick S Ling, Prakash Deedwania, et al.
Page
of 71
Search research articles
Search
Showing results (521-530 of 706) with videos related to
Sort By:
Page
of 71
Journal of the American College of Cardiology
|
May 7, 2011
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy
Benjamin M Scirica, Christopher P Cannon, Håkan Emanuelsson, et al.
International Journal of Cardiology
|
June 23, 2020
The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program
Clare Arnott, Brendon L Neuen, Hiddo J L Heerspink, et al.
Journal of the American Heart Association
|
April 16, 2017
Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding
Daniel Lindholm, Emil Hagström, Stefan K James, et al.
European Heart Journal
|
March 4, 2014
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry
Dharam J Kumbhani, Ph Gabriel Steg, Christopher P Cannon, et al.
Critical Pathways in Cardiology
|
March 15, 2008
Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry
Christopher P Cannon, Maria Cecilia Bahit, J Mark Haugland, et al.
American Heart Journal
|
May 21, 2019
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
Axel Åkerblom, Daniel M Wojdyla, Lars Wallentin, et al.
Journal of Clinical Lipidology
|
September 15, 2020
Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in the ODYSSEY CHOICE I trial
Eli M Roth, John J P Kastelein, Christopher P Cannon, et al.
JAMA Cardiology
|
January 21, 2026
Patient Engagement With Home Blood Pressure Monitoring
Ozan Unlu, David Zelle, Christopher P Cannon, et al.
Journal of the American College of Cardiology
|
June 7, 2005
Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates
Ajay J Kirtane, David M Leder, Sushrut S Waikar, et al.
Circulation. Cardiovascular Quality and Outcomes
|
January 12, 2012
Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program
Feng Qian, Frederick S Ling, Prakash Deedwania, et al.
Page
of 71